These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33015157)

  • 41. FX minirail balloon angioplasty for the treatment of patients with in-stent restenosis: a matched comparison of 6 months' outcome with conventional balloon angioplasty.
    Döven O; Pekdemir H; Camsari A; Cicek D; Katircibaşi MT; Atalay A; Akkus MN; Cin VG
    Heart Vessels; 2004 Sep; 19(5):230-6. PubMed ID: 15372298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of Circulating miRNA-320a/b and D-Dimer Improves Diagnostic Accuracy in Deep Vein Thrombosis Patients.
    Jiang Z; Ma J; Wang Q; Wu F; Ping J; Ming L
    Med Sci Monit; 2018 Apr; 24():2031-2037. PubMed ID: 29622762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
    El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
    J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X; Pandit RU; Han L; Li Y; Guo X
    Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
    Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
    Breuckmann F; Naber C; Beckert J; Schmermund A; Haude M; Baumgart D; Erbel R
    Int J Cardiol; 2006 Mar; 108(1):20-5. PubMed ID: 16516694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Schwalm T; Carlsson J; Meissner A; Lagerqvist B; James S
    EuroIntervention; 2013 Sep; 9(5):564-72. PubMed ID: 24058074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis.
    Alfonso F; Zueco J; Cequier A; Mantilla R; Bethencourt A; López-Minguez JR; Angel J; Augé JM; Gómez-Recio M; Morís C; Seabra-Gomes R; Perez-Vizcayno MJ; Macaya C;
    J Am Coll Cardiol; 2003 Sep; 42(5):796-805. PubMed ID: 12957423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
    Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo.
    Iaconetti C; De Rosa S; Polimeni A; Sorrentino S; Gareri C; Carino A; Sabatino J; Colangelo M; Curcio A; Indolfi C
    Cardiovasc Res; 2015 Sep; 107(4):522-33. PubMed ID: 25994172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
    Wu XA; Xie G; Li XQ; Wu HT; Wang X
    Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation.
    Stojkovic S; Jurisic M; Kopp CW; Koppensteiner R; Huber K; Wojta J; Gremmel T
    Atherosclerosis; 2018 Feb; 269():197-203. PubMed ID: 29366993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
    Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
    J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of circulating miRNA-208a-3p, miRNA-155-5p and miRNA-637 as potential non-invasive biomarkers and the possible mechanistic insights into pre- and postmenopausal osteoporotic females.
    Ismail SM; El Boghdady NA; Hamoud HS; Shabayek MI
    Arch Biochem Biophys; 2020 May; 684():108331. PubMed ID: 32151564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.